ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $281,771 | -78.2% | 31,518 | -65.3% | 0.00% | -87.5% |
| Q3 2022 | $1,292,000 | -80.0% | 90,849 | -79.4% | 0.01% | -92.0% |
| Q2 2022 | $6,446,000 | -26.9% | 441,518 | 0.0% | 0.10% | -7.4% |
| Q1 2022 | $8,817,000 | -2.1% | 441,518 | -14.3% | 0.11% | +18.7% |
| Q4 2021 | $9,007,000 | +317.8% | 515,000 | +87.3% | 0.09% | +911.1% |
| Q3 2021 | $2,156,000 | -23.8% | 275,000 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $2,830,000 | -36.6% | 275,000 | -19.4% | 0.02% | -33.3% |
| Q1 2021 | $4,464,000 | – | 341,269 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |